Antiemetic Drugs Market · GlobeNewswire Inc. Dublin, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The "Antiemetic Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's ...
Purpose: The drug interactions and adverse events that should be considered when individualizing antiemetic therapy for patients undergoing treatment for breast cancer are reviewed. Summary: A variety ...
Please provide your email address to receive an email when new articles are posted on . Over the past two decades, serotonin antagonists have revolutionized the way we prevent and manage ...
Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial From March 2022 to December 2023, a ...
Antiemetics are a type of medication that can help you feel better when you're nauseated (you feel like throwing up). There are both over-the-counter (OTC) and prescription antiemetics. If you have ...
The subcutaneous administration of granisetron, an antiemetic pharmaceutical drug (suitable for control of vomiting), achieves similar blood concentrations to those administered intravenously. This ...
A new antiemetic has been approved by the US Food and Drug Administration (FDA) for use in patients undergoing chemotherapy. The new drug, rolapitant (Varubi), has been developed and is marketed by ...
This study was an anonymized cross-sectional survey approved by the ethics committee. Survey items were generated from the clinical questions given in the ASCO guidelines. The survey was disseminated ...
More than 50% of patients undergoing cisplatin chemotherapy experience nausea and vomiting, despite receiving standard antiemetic therapy with serotonin receptor antagonist and corticosteroid ...
Chemotherapy-induced nausea and vomiting is an important problem in patients with brain tumors. Because of the high prevalence of seizures, most patients are given antiepileptic drugs. Motivated by a ...
Considerable progress has been made in improving the control of chemotherapy-induced emesis. The impact of available antiemetic options for patients receiving stem cell transplants is unclear, as few ...